2017
G. Cebers, Alexander, R. C., Haeberlein, S. Budd, Han, D., Goldwater, R., Ereshefsky, L., Olsson, T., Ye, N., Rosen, L., Russell, M., Maltby, J., Eketjäll, S., and Kugler, A. R.,
“AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease.”,
J Alzheimers Dis, vol. 55, no. 3, pp. 1039-1053, 2017.
M. Timmers, Barão, S., Van Broeck, B., Tesseur, I., Slemmon, J., de Waepenaert, K., Bogert, J., Shaw, L. M., Engelborghs, S., Moechars, D., Mercken, M., Van Nueten, L., Tritsmans, L., De Strooper, B., and Streffer, J. Rolf,
“BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants.”,
J Alzheimers Dis, vol. 56, no. 4, pp. 1437-1449, 2017.
D. L. Ebel, Torkilsen, C. G., and Ostrowski, T. D.,
“Blunted Respiratory Responses in the Streptozotocin-Induced Alzheimer's Disease Rat Model.”,
J Alzheimers Dis, vol. 56, no. 3, pp. 1197-1211, 2017.
E. Mariani, Chattat, R., Vernooij-Dassen, M., Koopmans, R., and Engels, Y.,
“Care Plan Improvement in Nursing Homes: An Integrative Review.”,
J Alzheimers Dis, vol. 55, no. 4, pp. 1621-1638, 2017.
M. M. Vasavada, Martinez, B., Wang, J., Eslinger, P. J., Gill, D. J., Sun, X., Karunanayaka, P., and Yang, Q. X.,
“Central Olfactory Dysfunction in Alzheimer's Disease and Mild Cognitive Impairment: A Functional MRI Study.”,
J Alzheimers Dis, vol. 59, no. 1, pp. 359-368, 2017.
E. Niemantsverdriet, Ottoy, J., Somers, C., De Roeck, E., Struyfs, H., Soetewey, F., Verhaeghe, J., Van den Bossche, T., Van Mossevelde, S., Goeman, J., De Deyn, P. Paul, Mariën, P., Versijpt, J., Sleegers, K., Van Broeckhoven, C., Wyffels, L., Albert, A., Ceyssens, S., Stroobants, S., Staelens, S., Bjerke, M., and Engelborghs, S.,
“The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.”,
J Alzheimers Dis, vol. 60, no. 2, pp. 561-576, 2017.
P. Lewczuk, Matzen, A., Blennow, K., Parnetti, L., Molinuevo, J. Luis, Eusebi, P., Kornhuber, J., Morris, J. C., and Fagan, A. M.,
“Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 55, no. 2, pp. 813-822, 2017.
G. P. Paraskevas, Kasselimis, D., Kourtidou, E., Constantinides, V., Bougea, A., Potagas, C., Evdokimidis, I., and Kapaki, E.,
“Cerebrospinal Fluid Biomarkers as a Diagnostic Tool of the Underlying Pathology of Primary Progressive Aphasia.”,
J Alzheimers Dis, vol. 55, no. 4, pp. 1453-1461, 2017.
S. P. Arnerić, Batrla-Utermann, R., Beckett, L., Bittner, T., Blennow, K., Carter, L., Dean, R., Engelborghs, S., Genius, J., Gordon, M. Forrest, Hitchcock, J., Kaplow, J., Luthman, J., Meibach, R., Raunig, D., Romero, K., Samtani, M. N., Savage, M., Shaw, L., Stephenson, D., Umek, R. M., Vanderstichele, H., Willis, B., and Yule, S.,
“Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team.”,
J Alzheimers Dis, vol. 55, no. 1, pp. 19-35, 2017.
S. Lista, Toschi, N., Baldacci, F., Zetterberg, H., Blennow, K., Kilimann, I., Teipel, S. J., Cavedo, E., Santos, A. Melo Dos, Epelbaum, S., Lamari, F., Dubois, B., Nisticò, R., Floris, R., Garaci, F., and Hampel, H.,
“Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study.”,
J Alzheimers Dis, vol. 59, no. 4, pp. 1327-1334, 2017.
I. Apostolova, Lange, C., Roberts, A., Igel, H. Joachim, Mäurer, A., Liese, S., Estrella, M., Prasad, V., Stechl, E., Lämmler, G., Steinhagen-Thiessen, E., and Buchert, R.,
“Challenges in Screening and Recruitment for a Neuroimaging Study in Cognitively Impaired Geriatric Inpatients.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 197-204, 2017.
L. L. Law, Schultz, S. A., Boots, E. A., Einerson, J. A., Dougherty, R. J., Oh, J. M., Korcarz, C. E., Edwards, D. F., Koscik, R. L., N Dowling, M., Gallagher, C. L., Bendlin, B. B., Carlsson, C. M., Asthana, S., Hermann, B. P., Sager, M. A., Johnson, S. C., Cook, D. B., Stein, J. H., and Okonkwo, O. C.,
“Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer's Disease.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 351-359, 2017.
L. L. Law, Schultz, S. A., Boots, E. A., Einerson, J. A., Dougherty, R. J., Oh, J. M., Korcarz, C. E., Edwards, D. F., Koscik, R. L., N Dowling, M., Gallagher, C. L., Bendlin, B. B., Carlsson, C. M., Asthana, S., Hermann, B. P., Sager, M. A., Johnson, S. C., Cook, D. B., Stein, J. H., and Okonkwo, O. C.,
“Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer's Disease.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 351-359, 2017.
A. Espinosa, Alegret, M., Pesini, P., Valero, S., Lafuente, A., Buendia, M., San José, I., Ibarria, M., Tejero, M. A., Giménez, J., Ruiz, S., Hernandez, I., Pujadas, F., Martínez-Lage, P., Munuera, J., Arbizu, J., Tárraga, L., Hendrix, S. B., Ruiz, A., Becker, J. T., Landau, S. M., Sotolongo-Grau, O., Sarasa, M., and Boada, M.,
“Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.”,
J Alzheimers Dis, vol. 57, no. 2, pp. 447-459, 2017.
R. O'Caoimh, Gao, Y., Svendovski, A., Gallagher, P., Eustace, J., and D Molloy, W.,
“Comparing Approaches to Optimize Cut-off Scores for Short Cognitive Screening Instruments in Mild Cognitive Impairment and Dementia.”,
J Alzheimers Dis, vol. 57, no. 1, pp. 123-133, 2017.
R. Savica, Wennberg, A. M. V., Hagen, C., Edwards, K., Roberts, R. O., Hollman, J. H., Knopman, D. S., Boeve, B. F., Machulda, M. M., Petersen, R. C., and Mielke, M. M.,
“Comparison of Gait Parameters for Predicting Cognitive Decline: The Mayo Clinic Study of Aging.”,
J Alzheimers Dis, vol. 55, no. 2, pp. 559-567, 2017.
A. N'Songo, Carrasquillo, M. M., Wang, X., Nguyen, T., Asmann, Y., Younkin, S. G., Allen, M., Duara, R., Custo, M. T. Greig, Graff-Radford, N., and Ertekin-Taner, N.,
“Comprehensive Screening for Disease Risk Variants in Early-Onset Alzheimer's Disease Genes in African Americans Identifies Novel PSEN Variants.”,
J Alzheimers Dis, vol. 56, no. 4, pp. 1215-1222, 2017.
A. R. Morgan, Touchard, S., O'Hagan, C., Sims, R., Majounie, E., Escott-Price, V., Jones, L., Williams, J., and B Morgan, P.,
“The Correlation between Inflammatory Biomarkers and Polygenic Risk Score in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 25-36, 2017.
D. A. Ferro, van Veluw, S. J., Koek, H. L., Exalto, L. G., and Biessels, G. Jan,
“Cortical Cerebral Microinfarcts on 3 Tesla MRI in Patients with Vascular Cognitive Impairment.”,
J Alzheimers Dis, vol. 60, no. 4, pp. 1443-1450, 2017.
T. Fladby, Pålhaugen, L., Selnes, P., Waterloo, K., Bråthen, G., Hessen, E., Almdahl, I. Selseth, Arntzen, K. - A., Auning, E., Eliassen, C. Fredrik, Espenes, R., Grambaite, R., Grøntvedt, G. Rolfseng, Johansen, K. Kunszt, Johnsen, S. Harald, Kalheim, L. Flem, Kirsebom, B. - E., Müller, K. Ivar, Nakling, A. Exner, Rongve, A., Sando, S. Botne, Siafarikas, N., Stav, A. Løvli, Tecelao, S., Timon, S., Bekkelund, S. Ivar, and Aarsland, D.,
“Detecting At-Risk Alzheimer's Disease Cases.”,
J Alzheimers Dis, vol. 60, no. 1, pp. 97-105, 2017.
T. Fladby, Pålhaugen, L., Selnes, P., Waterloo, K., Bråthen, G., Hessen, E., Almdahl, I. Selseth, Arntzen, K. - A., Auning, E., Eliassen, C. Fredrik, Espenes, R., Grambaite, R., Grøntvedt, G. Rolfseng, Johansen, K. Kunszt, Johnsen, S. Harald, Kalheim, L. Flem, Kirsebom, B. - E., Müller, K. Ivar, Nakling, A. Exner, Rongve, A., Sando, S. Botne, Siafarikas, N., Stav, A. Løvli, Tecelao, S., Timon, S., Bekkelund, S. Ivar, and Aarsland, D.,
“Detecting At-Risk Alzheimer's Disease Cases.”,
J Alzheimers Dis, vol. 60, no. 1, pp. 97-105, 2017.
S. Müller, Preische, O., Heymann, P., Elbing, U., and Laske, C.,
“Diagnostic Value of a Tablet-Based Drawing Task for Discrimination of Patients in the Early Course of Alzheimer's Disease from Healthy Individuals.”,
J Alzheimers Dis, vol. 55, no. 4, pp. 1463-1469, 2017.
A. Tort-Merino, Valech, N., Peñaloza, C., Grönholm-Nyman, P., León, M., Olives, J., Estanga, A., Ecay-Torres, M., Fortea, J., Martínez-Lage, P., Molinuevo, J. L., Laine, M., Rodríguez-Fornells, A., and Rami, L.,
“Early Detection of Learning Difficulties when Confronted with Novel Information in Preclinical Alzheimer's Disease Stage 1.”,
J Alzheimers Dis, vol. 58, no. 3, pp. 855-870, 2017.
A. Tort-Merino, Valech, N., Peñaloza, C., Grönholm-Nyman, P., León, M., Olives, J., Estanga, A., Ecay-Torres, M., Fortea, J., Martínez-Lage, P., Molinuevo, J. L., Laine, M., Rodríguez-Fornells, A., and Rami, L.,
“Early Detection of Learning Difficulties when Confronted with Novel Information in Preclinical Alzheimer's Disease Stage 1.”,
J Alzheimers Dis, vol. 58, no. 3, pp. 855-870, 2017.
J. Goossens, Laton, J., Van Schependom, J., Gielen, J., Struyfs, H., Van Mossevelde, S., Van den Bossche, T., Goeman, J., De Deyn, P. Paul, Sieben, A., Martin, J. - J., Van Broeckhoven, C., van der Zee, J., Engelborghs, S., and Nagels, G.,
“EEG Dominant Frequency Peak Differentiates Between Alzheimer's Disease and Frontotemporal Lobar Degeneration.”,
J Alzheimers Dis, vol. 55, no. 1, pp. 53-58, 2017.
] 